Transgenic T-cell receptor immunotherapy for cancer: building on clinical success

With the advent of immunotherapy as a realistic and promising option for cancer treatment, adoptive cellular therapies are gaining significant interest in the clinic. Whilst the recent successes of chimeric antigen receptor T-cell therapies for haematological malignancies are widely known, they have...

Descripción completa

Detalles Bibliográficos
Autores principales: Oppermans, Natasha, Kueberuwa, Gray, Hawkins, Robert E., Bridgeman, John S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7309387/
https://www.ncbi.nlm.nih.gov/pubmed/32613155
http://dx.doi.org/10.1177/2515135520933509

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7309387/
https://www.ncbi.nlm.nih.gov/pubmed/32613155
http://dx.doi.org/10.1177/2515135520933509

Ejemplares similares